Ticker Details
Exagen Inc.
IPO Date:	September 20, 2019
Sector:	Healthcare
Industry:	Diagnostics and Research
Market Cap:	$74.32M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.31 | 3.66%
Avg Daily Range (30 D):	$0.09 | 2.82%
Avg Daily Range (90 D):	$0.14 | 3.00%

Institutional Daily Volume
Avg Daily Volume:	.08M
Avg Daily Volume (30 D):	.23M
Avg Daily Volume (90 D):	.35M

Trade Size
Avg Trade Size (Sh.):	96
Avg Trade Size (Sh.) (30 D):	94
Avg Trade Size (Sh.) (90 D):	93

Institutional Trades
Total Institutional Trades:	73
Avg Institutional Trade:	$1.76M
Avg Institutional Trade (30 D):	$.64M
Avg Institutional Trade (90 D):	$1.81M
Avg Institutional Trade Volume:	.17M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.23M
Avg Closing Trade (30 D):	$.64M
Avg Closing Trade (90 D):	$2.42M
Avg Closing Volume:	215.41K

News

Feb 24, 2026 @ 2:00 PM Exagen Inc. to Announce Fourth Quarter and Full Ye... Source: Na

Jan 11, 2026 @ 8:00 PM Exagen Inc. Announces Select Preliminary 2025 Fina... Source: Na

Nov 11, 2025 @ 2:00 PM Exagen Inc. to Participate in Fourth Quarter Inves... Source: Ryan Douglas

Jun 13, 2024 @ 12:50 PM Why Fast-paced Mover Exagen (XGN) Is a Great Choic... Source: Zacks Equity Research

Jun 10, 2024 @ 12:03 PM Time to Play 5 Top-Ranked Stocks With Rising P/E? Source: Sanghamitra Saha

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.93	$-.2	$-.93
Diluted EPS	$-.93	$-.2	$-.93
Revenue	$66.58M	$16.63M	$66.58M
Gross Profit	$38.8M	$9.21M	$38.8M
Net Income / Loss	$-19.95M	$-4.67M	$-19.95M
Operating Income / Loss	$-14.07M	$-4.98M	$-14.07M
Cost of Revenue	$27.78M	$7.43M	$27.78M
Net Cash Flow	$10.18M	$-3.43M	$10.18M
PE Ratio